Moderna plans to launch 10 new marketed products over the next three years, aiming to diversify a revenue base, which is ...

I am recommending a COVID booster this spring for my highest-risk patients — those with immune system diseases and older ...

by Timothy McQuiston, Vermont Business Magazine The Vermont Department of Health reported last week that the number of ...

Patients who are immunocompromised still can receive a variety of vaccinations based on their specific needs, Cassandra ...

Have you ever wondered about what became of COVID vaccine companies after the pandemic settled down? Find out in this article ...

Overall, 72% of 36,949 infants were immunized in the 2023-2024 RSV season with either the bivalent RSV prefusion F protein ...

Moderna (NASDAQ:MRNA) accelerates cost cuts, trimming 2026 GAAP operating expenses by up to $500 million as COVID-19 vaccine ...

An aide to U.S. Health Secretary Robert F. Kennedy Jr. is seeking more information about three vaccines recommended by a ...

The anticipated rollout of updated Covid vaccines this fall might be at risk after a change by Health and Human Services ...

Moderna (MRNA) was in focus Thursday morning after the vaccine maker announced plans to expand its cost efficiency and ...

I am a 74-year-old man with no major health issues. Over the past several years, I have been getting a COVID booster in the spring with a second booster in the fall, as well as a flu shot. At my age, ...

The move follows Kennedy’s repeated statements about pharma-backed CDC advisory panels. The Health and Human Services ...